American Journal of Kidney Diseases
Volume 48, Issue 4 , Pages 537-545 , October 2006

The Epidemiology of Hemoglobin Levels in Patients With Type 2 Diabetes

  • Merlin C. Thomas, MBChB, PhD, FRACP

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Merlin C. Thomas, MBChB, PhD, FRACP, Danielle Alberti Memorial Centre for Diabetic Complications, Baker Medical Research Institute, PO Box 6492, Melbourne, VIC 8008, Australia.
  • ,
  • Con Tsalamandris, MBBS
  • ,
  • Richard J. MacIsaac, MBBS, BSc, PhD
  • ,
  • George Jerums, MD, FRACP

Received 3 March 2006 ,Accepted 13 June 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2006.06.011 on August 29, 2006.Support: The costs for measurement of iron storage indices were defrayed by a grant from Jansen-Cilag (manufacturer of epoetin). The costs of erythropoietin levels were defrayed by a grant from Amgen (manufacturers of darbepoetin). Neither party had a role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the paper for publication. M.C.T. and G.J. were both members of the Jannsen-Cilag Endocrinology advisory panel (2001 to 2002). Potential conflicts of interest: None.

PII: S0272-6386(06)01082-1

doi: 10.1053/j.ajkd.2006.06.011

American Journal of Kidney Diseases
Volume 48, Issue 4 , Pages 537-545 , October 2006